Review: New direct-acting antivirals in the development for hepatitis C virus infection
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review: New direct-acting antivirals in the development for hepatitis C virus infection
Authors
Keywords
-
Journal
Therapeutic Advances in Gastroenterology
Volume 3, Issue 3, Pages 191-202
Publisher
SAGE Publications
Online
2010-03-27
DOI
10.1177/1756283x10363055
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results
- (2009) Yves Benhamou et al. HEPATOLOGY
- 90 PRECLINICAL STUDIES OF ANA598 COMBINED WITH OTHER ANTI-HCV AGENTS DEMONSTRATE POTENTIAL OF COMBINATION TREATMENT
- (2009) P. Thompson et al. JOURNAL OF HEPATOLOGY
- 1044 TELAPREVIR IN HEPATITIS C GENOTYPE-1-INFECTED PATIENTS WITH PRIOR NON-RESPONSE, VIRAL BREAKTHROUGH OR RELAPSE TO PEGINTERFERON- ALFA-2A/B AND RIBAVIRIN THERAPY: SVR RESULTS OF THE PROVE3 STUDY
- (2009) M. Manns et al. JOURNAL OF HEPATOLOGY
- 1046 FIRST-IN-MAN DEMONSTRATION OF POTENT ANTIVIRAL ACTIVITY WITH A NUCLEOSIDE POLYMERASE (R7128) AND PROTEASE (R7227/ITMN-191) INHIBITOR COMBINATION IN HCV: SAFETY, PHARMACOKINETICS, AND VIROLOGIC RESULTS FROM INFORM-1
- (2009) E.J. Gane et al. JOURNAL OF HEPATOLOGY
- 1049 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF NITAZOXANIDE PLUS PEGINTERFERON AND RIBAVIRIN IN HCV GENOTYPE 1 PATIENTS: INTERIM ANALYSIS SHOWS INCREASE IN EVR
- (2009) B. Bacon et al. JOURNAL OF HEPATOLOGY
- 1052 ANTIVIRAL ACTIVITY OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN FOR 28 DAYS IN TREATMENT NAIVE PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1
- (2009) I. Jacobson et al. JOURNAL OF HEPATOLOGY
- 89 SAFETY, PLASMA PHARMACOKINETICS, AND ANTI-VIRAL ACTIVITY OF SCY-635 IN ADULT PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
- (2009) S. Hopkins et al. JOURNAL OF HEPATOLOGY
- 13 A PHASE 2, RANDOMIZED STUDY OF HCV-796 IN COMBINATION WITH PEGYLATED-INTERFERON (PEG) PLUS RIBAVIRIN (RBV) VERSUS PEG PLUS RBV IN HEPATITIS C VIRUS GENOTYPE-1 INFECTION
- (2009) P. Pockros et al. JOURNAL OF HEPATOLOGY
- 1056 MK-7009 SIGNIFICANTLY IMPROVES RAPID VIRAL RESPONSE (RVR) IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C (CHC) GENOTYPE 1 INFECTION
- (2009) M.P. Manns et al. JOURNAL OF HEPATOLOGY
- 11 OPERA-1 TRIAL: INTERIM ANALYSIS OF SAFETY AND ANTIVIRAL ACTIVITY OF TMC435 IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS
- (2009) M. Manns et al. JOURNAL OF HEPATOLOGY
- 95 EFFICACY AND SAFETY OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN PREVIOUSLY NULL-RESPONDER GENOTYPE 1 HCV PATIENTS
- (2009) D.R. Nelson et al. JOURNAL OF HEPATOLOGY
- Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: A study in monozygotic and dizygotic twins
- (2009) Janne Makkonen et al. JOURNAL OF HEPATOLOGY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
- (2009) Christophe Hézode et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy
- (2008) Peter Ferenci et al. GASTROENTEROLOGY
- R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin
- (2008) Paul J. Pockros et al. HEPATOLOGY
- Dr. H. Butt tribute
- (2008) Keith D. Lindor HEPATOLOGY
- High relapse rate seen at week 72 for patients treated with R1626 combination therapy
- (2008) Paul Pockros et al. HEPATOLOGY
- The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus
- (2008) Robert Flisiak et al. HEPATOLOGY
- The G protein-coupled receptor G2A: Involvement in hepatic lipid metabolism and gallstone formation in mice
- (2008) Laura E. Johnson et al. HEPATOLOGY
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
- 66 POTENT ANTIVIRAL ACTIVITY OF THE HCV NUCLEOSIDE POLYMERASE INHIBITOR R7128 WITH PEG-IFN AND RIBAVIRIN: INTERIM RESULTS OF R7128 500MG BID FOR 28 DAYS
- (2008) J. Lalezari et al. JOURNAL OF HEPATOLOGY
- 68 RANDOMIZED CONTROLLED TRIAL OF NITAZOXANIDE-PEGINTERFERON-RIBAVIRIN, NITAZOXANIDE-PEGINTERFERON AND PEGINTERFERON-RIBAVIRIN IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 4
- (2008) J.F. Rossignol et al. JOURNAL OF HEPATOLOGY
- The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle
- (2008) Guo-Hua Qiu et al. JOURNAL OF HEPATOLOGY
- Pro-hepcidin is unable to degrade the iron exporter ferroportin unless maturated by a furin-dependent process
- (2008) Bruno Gagliardo et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started